Kynurenine pathway metabolite alterations in Down syndrome and Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2025, v. 21, n. 5, p. 1, doi. 10.1002/alz.70197
- By:
- Publication type:
- Article
Works by Singulani, Monique Patricio
Results: 6
1
2
Lithium as a pharmacological approach to treat behavioral complications in Alzheimer's disease: a preclinical study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, p. 1, doi. 10.1002/alz.090340
- By:
- Publication type:
- Article
3
'Latent' mild behavioral impairment as a potential diagnostic strategy for preclinical Alzheimer's disease: an animal model study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, p. 1, doi. 10.1002/alz.087517
- By:
- Publication type:
- Article
4
An Overview of the Effects of Lithium on Alzheimer's Disease: A Historical Perspective.
- Published in:
- Pharmaceuticals (14248247), 2025, v. 18, n. 4, p. 532, doi. 10.3390/ph18040532
- By:
- Publication type:
- Article
5
Inhibition of TRPM2 by AG490 Is Neuroprotective in a Parkinson's Disease Animal Model.
- Published in:
- Molecular Neurobiology, 2022, v. 59, n. 3, p. 1543, doi. 10.1007/s12035-022-02723-8
- By:
- Publication type:
- Article
6
Effects of strength training on osteogenic differentiation and bone strength in aging female Wistar rats.
- Published in:
- Scientific Reports, 2017, p. 42878, doi. 10.1038/srep42878
- By:
- Publication type:
- Article